CeriBell Inc (CBLL) Total Business Assets

Graphic logo of CeriBell Corp (CBLL)

This chart of CeriBell, Inc. (CBLL) total assets, which reach 187.02, confirms capitalization driven by the implementation of high-margin SaaS solutions for brain activity analysis. CeriBell, Inc. (CBLL) generates revenue by providing cloud services to intensive care units for the rapid recognition of epileptic seizures. Steady growth is supported by the efficient operation of mobile diagnostic complex production facilities and timely equipment modernization.

CeriBell, Inc. (CBLL): Cumulative Company Assets from 10/12/2024 to 10/28/2026

Analytical breakdowns for CeriBell Corp (CBLL)

- price and consensus price forecast:
Price Chart ceribell.com|CBLL - Price Target Chart
- market capitalization data:
Market Capitalization CeriBell EEG|CBLL - Enterprise Value
- book capitalization data:
Net Asset Value per Share CeriBell|CBLL - Company Net Assets|Market Capitalization to Book Value Ratio ceribell.com|CBLL - Aggregate Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio CeriBell, Inc.|CBLL - Long-Term Debt to Equity|Current Liabilities to Capital CeriBell EEG|CBLL - Company Aggregate Debts|Debt to Book Value CeriBell EEG|CBLL - Company Long-Term Debts|Short-Term Debt CeriBell
Summary company analysis:CeriBell, Inc.
Finished products of CeriBell

Total assets reflect the aggregate volume of CeriBell, Inc. (CBLL) resources, reconstructed via a reverse ROA calculation to assess the speed of capital accumulation. An analysis of all company resources confirms the effectiveness of investments in intellectual capital, including the hiring of AI engineers to expand EEG systems. The growth of this metric, coupled with a stable cash flow, verifies the resilience of the R&D core. This indicator's trend serves as a guarantee of the financial strength of CeriBell, Inc. (CBLL) as it scales its business.

Competing companies

BIIB (biogen.com) - Aggregate Company Assets|Aggregate Company Assets Neurocrine Biosciences, Inc. (NBIX)|Total Business Assets Regencell Bioscience Ltd|Axsome Therapeutics Inc - Company Total Assets|Company Assets ACADIA Corp ACAD|Cumulative Company Assets XENE (Xenon Pharmaceuticals)|vikingtherapeutics.com - Company Total Assets|Aggregate Company Assets Supernus (SUPN)|CPRX: Aggregate Asset Value|Aggregate Company Assets DNLI|Harmony Corp (HRMY) - Company Assets|Company Total Assets BHVN|Cumulative Company Assets amylyx.com|Trevi Therapeutics, Inc. - Company Total Assets|Company Assets PRAX (Praxis Precision Medicines Inc)|Aggregate Company Assets Anavex Corp|Aggregate Asset Value Prothena PRTA|Company Total Assets ALEC (Alector Therapeutics)|ANNX - Company Total Asset Base|omeros.com (OMER) - Company Total Assets|Neurogene Inc (NGNE) - Aggregate Company Assets|Company Total Assets ACIU (AC Immune Corp)|Company Assets VYGR|Aggregate Company Assets Neumora Therapeutics (NMRA)|Aggregate Company Assets SCLX (scilexholding.com)|Aggregate Company Assets Tevogen Bio TVGN|ACOG - Aggregate Company Assets|Cumulative Company Assets Cognition Therapeutics, Inc. (CGTX)|IKT - Aggregate Asset Value|Cassava Sciences, Inc. - Company Total Assets|ASRT (Assertio) - Company Total Asset Base|Aggregate Company Assets Coya Therapeutics Inc (COYA)|Total Business Assets VistaGen Therapeutics Inc|Company Total Assets OVID (Ovid Therapeutics Inc.)|Cumulative Company Assets Acumen Pharmaceuticals, Inc ABOS|Cumulative Company Assets CRVO|Company Total Asset Base Alterity Therapeutics Ltd. ATHE|CLNN: Company Total Assets|PEPG - Cumulative Company Assets|Jupiter Neurosciences (JUNS) - Company Total Assets|RLMD (Relmada Corp) - Aggregate Company Assets|Aggregate Company Assets Annovis Bio, Inc.|Aggregate Company Assets GRCE|Aggregate Company Assets Firefly Neuroscience (AIFF)|Aggregate Company Assets KLTO (anewmeds.com)|NRSN - Aggregate Company Assets|Total Business Assets Reviva Pharmaceuticals, Inc. RVPH|MTVA (MetaVia, Inc.) - Company Total Assets|neuraxis.com (NRXS) - Company Assets|HSDT: Cumulative Company Assets|PASG (Passage Bio) - Company Total Assets|NEUP - Aggregate Company Assets|Aggregate Asset Value NERV|Athira Pharma, Inc. - Aggregate Company Assets|Company Assets addextherapeutics.com (ADXN)|Alzamend Neuro - Company Total Assets|Cumulative Company Assets Cyclerion Therapeutics Inc. CYCN|PTIX (Protagenic) - Company Total Assets|KTTA: Company Assets|Aggregate Company Assets cortigent.com CRGT|avenuetx.com (ATXI) - Aggregate Asset Value|BCLI: Company Total Assets|Company Total Asset Base Cara Therapeutics Inc.|Company Total Assets Chromocell Therapeutics Corporation (CHRO)|Aggregate Company Assets eliemtx.com (ELYM)|ITCI: Company Total Assets|longboardpharma.com - Company Assets|MRNS - Aggregate Company Assets|NKGN: Aggregate Company Assets|NeuroBo (NRBO) - Aggregate Company Assets|Aggregate Company Assets Sage Therapeutics Inc|SNPX - Cumulative Company Assets|Aggregate Asset Value trevena.com|VIGL (Vigil Neuroscience) - Company Total Assets|Company Total Asset Base WENA (anewmeds.com)|CERE - Aggregate Company Assets